Please Wait...

Jeremiah Rehm

Translation skills

Main profile

Jeremiah Rehm
Jeremiah Rehm
Clinical Solutions Specialist

Jeremiah has been an innovator in Life Sciences for more than 13 years -- the last 8 of those designing and maintaining Clinical Trial Management Systems. Prior to joining Bioclinica, he was a technology consultant and led the product management team for eClinical products acquired by Bioclinica. One of Jeremiah's specialties is in the use of Microsoft applications to consolidate and analyze operational study information, including translation of this data into meaningful performance metrics.

Blogs

Regulatory authorities require clinical trial progress to be monitored. The site visit report, known as the Monitor Visit Report (MVR), is where sponsors provide evidence that all regulated activities have been completed along with documentation of the outcome. These reports are open to regulatory inspection at any time during a study, as well as after, and even post product approval.

CTMS and MVR, Across the Great Divide
As anyone in pharma knows, our industry is undergoing major change; clinical trials are rapidly evolving and eClinical technologies are becoming more sophisticated by the day. Meanwhile site monitoring continues to be one of the most critical, costly, and labor-intensive activities in a clinical trial. Looking for a better way to address this, many organizations have made the switch from conventional CTMS to the "Microsoft Office-Smart" model.

CTMS & eTMF seamless integration at ShareFEST 2013

We've recently heard quite a bit of industry conversation regarding the touch-points between clinical trial management systems (CTMS) and electronic trial master files (eTMF).  In addition to this blog post, we will be discussing this evolving topic in greater depth at the upcoming ShareFEST 2013 conference i

There have recently been a lot of industry conversations regarding the touch-points between clinical trial management systems (CTMS) and Electronic Master Trial Files (eTMF). While there are many questions concerning the integration of CTMS and eTMF, they can mostly be boiled down to the following three:

There has been quite a lot of discussion within the clinical trial management industry regarding new improved CTMS and study setup products. These new CTMS solutions all seem to focus on updating the traditional model with a slick, user-friendly interface as well as overall improved functionality (which is great).

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

If study sites R asking 4 accuracy & speed in site payments & the clinical financial folks R demanding better budge… https://t.co/FR4QE2QEqx
bioclinica (1 hour ago)
See you at #DIA2018 ! Here's when & where to find @Bioclinica in our exhibit, at Innovation Theater (Site Payments!… https://t.co/z4hPha2Ppo
bioclinica (Yesterday)
Reminder: Today's webinar on Clinical Endpoint Adjudication kicks off at 1 PM Eastern. > https://t.co/1IU9TVFCFA
bioclinica (5 days ago)
In a new go-to-guide on conducting #Alzheimer's clinical trials, @bioclinica experts Joyce Suhy, Marieke Cajal, Luc… https://t.co/SaBFm3L9CL
bioclinica (5 days ago)
Clinical Endpoint Adjudication Webinar. Join us in a live online event this Friday, (6/15) Details & reg. > https://t.co/uBjlgSMnDS
bioclinica (6 days ago)
Clinical Endpoint Adjudication webinar this Friday! Interested in establishing a universal clinical vocabulary to i… https://t.co/uPD992tSaY
bioclinica (1 week ago)

Latest Blogs:

Latin America: Benefit from the Right Partner
Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen